Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DUVELISIB vs EDOXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DUVELISIB vs EDOXABAN: Safety Overview

Metric DUVELISIB EDOXABAN
Total FAERS Reports 757 8,334
Deaths Reported 165 992
Death Rate 21.8% 11.9%
Hospitalizations 282 4,729
Average Patient Age 64.7 yrs 77.2 yrs
% Female Patients 40.0% 46.5%
FDA Approval Date Sep 24, 2018 Jan 8, 2015
Manufacturer Secura Bio, Inc Daiichi Sankyo Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription